The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Long non‐coding RNA UCA 1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
Open accessAbstract
Chemotherapy is a reasonable alternative to cystectomy in patients with invasive and advanced bladder cancer. However, bladder cancer cells often develop drug resistance to these therapies, and ~ 50% of patients with advanced bladder cancer do not respond to chemotherapy. Recent studies have shown that long non‐coding RNA (lnc RNA) is involved in the development of chemoresistance. Here we investigated the role of the urothelial cancer‐associated 1 (UCA 1) lnc RNA in cisplatin resistance during chemotherapy for bladder cancer. We showed that cisplatin‐based chemotherapy results in up‐regulation of UCA 1 expression in patients with bladder cancer. Similarly, UCA 1 levels are increased in cisplatin‐resistant bladder cancer cells. Over‐expression of UCA 1 significantly increases the cell viability during cisplatin treatment, whereas UCA 1 knockdown reduces the cell viability during cisplatin treatment. UCA 1 inhibition also partially overcomes drug resistance in cisplatin‐resistant T24 cells. Furthermore, we showed that UCA 1 positively regulates expression of wingless‐type MMTV integration site family member 6 (Wnt6) in human bladder cancer cell lines. UCA 1 and Wnt6 expression is also positively correlated in vivo. Up‐regulation of UCA 1 activates Wnt signaling in a Wnt6‐dependent manner. We finally demonstrate that UCA 1 increases the cisplatin resistance of bladder cancer cells by enhancing the expression of Wnt6, and thus represents a potential target to overcome chemoresistance in bladder cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206928 · Cited by 2,189
The hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1021 · Cited by 1,238
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
James, N. D., Hussain, S. A., Hall, E., Jenkins, P., Tremlett, J., Rawlings, C., Crundwell, M., Sizer, B., Sreenivasan, T., Hendron, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106106 · Cited by 962
Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs
Moran, V. A., Perera, R. J., & Khalil, A. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks296 · Cited by 637
Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., & Qiu, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.033 · Cited by 549
Wang, X.-S., Zhang, Z., Wang, H.-C., Cai, J.-L., Xu, Q.-W., Li, M.-Q., Chen, Y.-C., Qian, X.-P., Lu, T.-J., Yu, L.-Z., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0134 · Cited by 480
Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K., & Akimitsu, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.008 · Cited by 424
Kim, W.-J., Kim, E.-J., Kim, S.-K., Kim, Y.-J., Ha, Y.-S., Jeong, P., Kim, M.-J., Yun, S.-J., Lee, K., Moon, S.-K., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-3 · Cited by 398
Cited by
Long Noncoding RNA and Cancer: A New Paradigm
Bhan, A., Soleimani, M., & Mandal, S. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2634 · Cited by 2,861
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Liu, B., Sun, L., Liu, Q., Gong, C., Yao, Y., Lv, X., Lin, L., Yao, H., Su, F., Li, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.004 · Cited by 908
Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225758 · Cited by 605
lncRNAs and microRNAs with a role in cancer development
Liz, J., & Esteller, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.015 · Cited by 512
Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
Lin, C., & Yang, L. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.008 · Cited by 488
Bian, Z., Jin, L., Zhang, J., Yin, Y., Quan, C., Hu, Y., Feng, Y., Liu, H., Fei, B., Mao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23892 · Cited by 363
Xue, M., Chen, W., Xiang, A., Wang, R., Chen, H., Pan, J., Pang, H., An, H., Wang, X., Hou, H., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0714-8 · Cited by 359
LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p
Nie, W., Ge, H.-J., Yang, X.-Q., Sun, X., Huang, H., Tao, X., Chen, W.-S., & Li, B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.11.024 · Cited by 353
Wang, F., Ying, H.-Q., He, B.-S., Pan, Y.-Q., Deng, Q.-W., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2015) · Oncotarget · doi:10.18632/oncotarget.3219 · Cited by 348
YiRen, H., YingCong, Y., Sunwu, Y., Keqin, L., Xiaochun, T., Senrui, C., Ende, C., XiZhou, L., & Yanfan, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0743-3 · Cited by 337
Liquid biopsy: a step forward towards precision medicine in urologic malignancies
Di Meo, A., Bartlett, J., Cheng, Y., Pasic, M. D., & Yousef, G. M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0644-5 · Cited by 330
Circulating long non-coding RNAs in cancer: current status and future perspectives
Qi, P., Zhou, X.-Y., & Du, X. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0524-4 · Cited by 312
From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
Dhamija, S., & Diederichs, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30039 · Cited by 272
Zhang, Z., Yin, J., Lu, C., Wei, Y., Zeng, A., & You, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1139-6 · Cited by 265
Post-transcriptional regulation of cytokine and growth factor signaling in cancer
Vlasova-St. Louis, I., & Bohjanen, P. R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.11.004 · Cited by 47
Metadata
- Authors
- Fan, Y., Shen, B., Tan, M., Mu, X., Qin, Y., Zhang, F., & Liu, Y.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2014-02-20
- Volume
- 281
- Issue
- 7
- Pages
- 1750-1758
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W1978586737
- Cited by
- 370
- References
- 33
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.